Lung Cancer Pills That Target EGFR May Quietly Weaken the Heart, Study Warns
A retrospective Chinese cohort study reports rare but serious cardiovascular toxicity, including heart failure and QTc prolongation, in patients with ...
A retrospective Chinese cohort study reports rare but serious cardiovascular toxicity, including heart failure and QTc prolongation, in patients with ...
A new retrospective study finds that about one in ten cancer patients undergoing jaw surgery for medication-related osteonecrosis developed silent ...
A new systematic review and meta-analysis of randomized trials finds that current evidence does not confirm a consistent cardioprotective effect ...
A case report from Zhongshan Hospital describes how early second-line immunosuppression with tofacitinib and mycophenolate mofetil rescued a 77-year-old woman ...
A new case report describes a 70-year-old lung cancer patient with no cardiovascular risk factors who suffered a massive heart ...
A new meta-analysis finds that cancer patients undergoing transcatheter mitral valve repair have similar procedural success to other patients but ...
A new clinical case report shows that the oral HER2 inhibitor lapatinib, with its short half-life and low cardiac toxicity, ...
Updated 2026 expert recommendations provide a comprehensive, evidence-graded framework for preventing, diagnosing and treating the rare but often fatal myocarditis ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine